Biotech Company GenoPalate Closes $4 Million Series A Financing-Investment In Personalized Healthy Eating Continues To Grow
Retrieved on:
Wednesday, December 30, 2020
MILWAUKEE, Dec. 30, 2020 /PRNewswire-PRWeb/ -- GenoPalate, Inc. , a Milwaukee-based early-stage nutritional genomics company, has completed a $4 million round of equity financing from local investors.
Key Points:
- MILWAUKEE, Dec. 30, 2020 /PRNewswire-PRWeb/ -- GenoPalate, Inc. , a Milwaukee-based early-stage nutritional genomics company, has completed a $4 million round of equity financing from local investors.
- Using proprietary algorithms GenoPalate interprets the customer's DNA to help determine a personalized nutrition profile that shows them which foods are good and bad for their health.
- "To truly eat healthy and apply daily food behavior to preventing chronic metabolic diseases, one must personalize his or her nutrition.
- That combined with millions of nutritional variables produces a personalized report recommending foods that will provide the most benefit for a person's health.